← Insider Monitor
Lipocine Inc. logo
LPCN

Lipocine Inc.

Nasdaq · Pharmaceutical Preparations

3
Insider trades
0
Congress trades

Company Overview

A concise company profile alongside the latest public filing activity.

Lipocine Inc. is a pharmaceutical company developing oral drug products based on its proprietary oral delivery technologies, with a focus on men's and women's health conditions such as testosterone deficiency and other hormone-related disorders.

Industry
Pharmaceutical Preparations
Headquarters
Salt Lake City, X1
Exchange
Nasdaq

Company profile sourced from SEC filings.

Corporate Insider Trades

Open-market purchases and sales by directors, officers, and other company insiders.

InsiderTypeValueDate
Higuchi John W.DirectorBuy$36KSep 30, 2026
Higuchi John W.DirectorBuy$19KSep 29, 2026
Higuchi John W.DirectorBuy$27KSep 28, 2026

Source: SEC EDGAR Form 4 filings

Congressional Trades

Recent disclosures by members of the U.S. House and Senate.

No recent congressional disclosures found for LPCN.

Source: Senate eFD and House Clerk STOCK Act disclosures

Get notable LPCN activity by email

Free alerts for the insider and congressional trades worth watching.

Leave mobile blank for email only. Outside US/Canada, include + and your country code.

SMS Terms and Privacy Policy.

By submitting your email address, you will receive a free subscription to the MySmarTrend e-letter, and offers from us and our affiliates that we think might interest you. You can unsubscribe at any time. Privacy Policy.

For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.